Expert Team
Dr. Feng Yang, male, received his PhD degree from Chinese Academy of Sciences in 2003, majoring in synthesis and application of carbohydrates (anti-cancer oligosaccharides). In April 2008, he joined the San Diego biopharmaceutical industry and worked at Nitto Denko Technical Incorporation, where he was involved in the delivery of small-scale pharmaceutical RNAs and targeted anti-cancer drugs, and Abgent, where he was responsible for peptide synthesis and antigenic modification of immunoproteins and development of antibody diagnostic reagents. In 2011, he joined Broadpharm. In 2011, he joined Broadpharm as Director of Product Development and became one of the key shareholders to lead and develop PEG LINKER products in the field of immunobiologic protein modification and drug delivery technology and external services; and since early 2014, he has been helping Avidity Nanomedicines to develop a new generation of polymeric nano drug delivery technology as a collaborative research. polymeric nanodrug delivery technology.
Ying Li. Graduated from the University of Iowa College of Medicine in 2014 with a PhD in Pharmacology, one of the founders of Yichang Borenpharm Co., Ltd.
From 2007 to 2008, she worked as a technician in the Department of Pharmacology at the University of California, San Diego School of Medicine and Nitto Denko Technical Incorporation, where she was engaged in the research of hypertensive drugs and the determination of drug delivery efficacy of anti-cancer targeted drugs. He is currently a postdoctoral employee at the UCSD Veterans Hospital Nephrology Research Unit, where he is a consultant for decision making on drug model screening of new targeted drugs.
WeChat Official Account
© COPYRIGHT 2022 Yichang Borenpharm Co., Ltd.. ALL RIGHTS RESERVED | SEO | Power by 300.cn
